InvestorsHub Logo

scottsmith

01/03/19 3:25 PM

#253321 RE: groton68 #253317

So much unadulterated BS from Leo in this letter to shareholders!

"Preclinical tests are being performed at Beth Israel Deaconess Medical Center testing Kevetrin in combination with Pfizer, Inc.'s multikinase inhibitor drugs as potential new therapies for renal cancer and melanoma. We have seen the data and it is very exciting to us, but, again, confidentiality agreements prevent us from providing any details at this time."

https://www.biospace.com/article/releases/cellceutix-ceo-discusses-corporate-developments-in-2012-and-plans-for-2013-/?keywords=%25myeloma%25

Crooked Leo needs to be jailed immediately. Many poor shareholders don't realize Prurisol results are out.